Caprotec Bioanalytics logo — Experience Precision Protein Targeting with Proprietary Tech...

Caprotec Bioanalytics

Experience Precision Protein Targeting with Proprietary Technology

Founded 2006 10001+ employees Series B Total: $21.10M Biotechnology, Health Care +1

General Information

Company Name Caprotec Bioanalytics
Founded Year 2006
Employees 10001+
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series B
Social

Get notified when Caprotec Bioanalytics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Caprotec Bioanalytics

Caprotec Bioanalytics offers precision protein targeting with its proprietary Capture Compound Mass Spectrometry (CCMS) Technology. This innovative method efficiently isolates proteins within complex mixtures using Capture Compounds™, providing clear advantages over traditional shotgun methodologies. Founded in 2006, the company operates within the Biotechnology, Health Care, and Pharmaceutical industries. As of 09 May 2011, Caprotec secured a $2.10M Series B investment. With its unique technology and potential in the proteomics community, Caprotec Bioanalytics is poised for further growth and impactful contributions in the biotech sector.

Taxonomy: Proteomics, Mass Spectrometry, Capture Compounds, Bioanalytics, Protein Targeting, Technology, Research Models, Preclinical Services, Discovery Research Services, Biologics Testing Solutions, Microbial Identification, Endotoxin Testing, Early Discovery, Safety Testing, Agrochemical

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• - 09 May 2011
Series B •••••• 4
Investor Investor Investor
•••• ••••
13 May 2010
Grant •••••• - 15 Dec 2008
Series B •••••• 3
Investor Investor
•••• ••••
10 Jan 2008
Venture Round •••••• 1 •••• •••• 22 Nov 2007

Caprotec Bioanalytics Alternatives & Competitors

Caprotec Bioanalytics vs

Providing innovative research models and services to advance scientific progress in the Japanese mar...

14 employees
Caprotec Bioanalytics vs

Together, We Create Healthier Lives

IPO
14659 employees
Biotechnology, Health Care
Caprotec Bioanalytics vs
Bixa
Bixa United States

Capture attention, influence your audience, transform your business—with direct research insights fr...

8 employees

FAQ About Caprotec Bioanalytics

Experience Precision Protein Targeting with Proprietary Technology
Caprotec Bioanalytics was founded in 2006.
Caprotec Bioanalytics operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Caprotec Bioanalytics has approximately 10001+ employees.
Caprotec Bioanalytics has completed 5 funding rounds, raising a total of $21.10M. The latest funding stage is Series B.
Top alternatives and competitors to Caprotec Bioanalytics include 日本チャールス・リバー株式会社, Charles River Laboratories, Bixa, MEDIOS, Hesperos Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Caprotec Bioanalytics and 日本チャールス・リバー株式会社 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Caprotec Bioanalytics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy